Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

C3_KIDNEY_NOTRENALPELVIS_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C64 Hospital discharge: ICD-9 — 1890 Hospital discharge: ICD-8 — 1890 Cause of death: ICD-10 — C64 Cause of death: ICD-9 — 1890 Cause of death: ICD-8 — 1890 Cancer registry: Topography ICD-O-3 — C64 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	4073
4. Check minimum number of events None	4073
5. Include endpoints C3_KIDNEY_CLEAR_CELL_CARCINOMA_EXALLC C3_KIDNEY_PAPILLARYADENO_EXALLC	4073
6. Filter based on genotype QC (FinnGen only)	4073

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_KIDNEY_NOTRENALPELVIS_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_KIDNEY_CLEAR_CELL_CARCINOMA_EXALLC\|C3_KIDNEY_PAPILLARYADENO_EXALLC
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C64
HD_ICD_9	1890
HD_ICD_8	1890
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C64
COD_ICD_9	1890
COD_ICD_8	1890
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C64
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4073	1476	2597
Unadjusted period prevalence (%)	0.91	0.50	1.14
Median age at first event (years)	66.88	66.02	67.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3135: Matched controls
31359

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

WX302

NOMESCO Finland

Thoracal epidural anesthesy

26.1

323.0

536

245

197

Kela drug reimbursment

Sunitinib

+∞

323.0

338

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

4527.4

323.0

729

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

323.0

1413

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

323.0

1012

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

323.0

325

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

806

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

401.1

323.0

1990

135

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

310

JN4AD

NOMESCO Finland

Body CT examination

25.3

323.0

825

436

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

1286.4

323.0

621

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

4503599627370496.0

323.0

2811

B01AB10

ATC

tinzaparin; parenteral

15.5

323.0

733

606

KAC10

NOMESCO Finland

Total nephrectomy with capsule

1240.4

323.0

826

JN4BD

NOMESCO Finland

Extensive body CT

14.9

323.0

829

737

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

423.9

323.0

377

KAD00

NOMESCO Finland

Partial nephrectomy

572.3

323.0

402

JN4CD

NOMESCO Finland

Very extensive body CT

31.1

323.0

493

187

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.6

310.2

921

1862

L01XE04

ATC

[U] sunitinib; oral

+∞

293.3

277

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

12.4

287.3

549

529

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

280.4

265

C61

ICD-10 Finland

Malignant neoplasm of prostate

191.8

271.1

280

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

36.5

268.7

349

107

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

261.1

247

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

260.0

246

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1285.0

247.0

238

TPH07

NOMESCO Finland

Cathetrisation of artery

6.1

243.1

748

1528

H02AB02

ATC

dexamethasone; systemic

29.3

229.5

315

119

A03FA01

ATC

metoclopramide; systemic, rectal

5.6

228.4

755

1671

WX408

NOMESCO Finland

General anesthesy, balanced

3.9

226.8

1205

4303

1502

Kela drug reimbursment

Cabozantinib

+∞

202.2

192

KAC00

NOMESCO Finland

Nephrectomy

239.6

198.0

202

3012

Kela drug reimbursment

Cabozantinib

+∞

193.7

184

B01AB05

ATC

enoxaparin; parenteral

3.3

191.2

1310

5555

C64.80

ICD-10 Finland

Wilms tumour

2058.8

190.4

183

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

163.6

176.5

185

U75

ICPC

Malignant neoplasm of kidney

885.0

172.6

168

159

Kela drug reimbursment

Pazopanib

+∞

172.5

164

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

159.7

152

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.2

158.5

1071

4357

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

150.6

1714

9659

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

139.4

149.7

159

Z51.5

ICD-10 Finland

Palliative care

10.8

149.0

299

302

7125

FHL

Nephrectomy (extrrafascial)

757.6

148.3

145

A04AA02

ATC

granisetron; systemic, transdermal

227.9

148.3

152

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

145.9

139

XX3DW

NOMESCO Finland

Time consuming IT work

6.8

145.4

393

646

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

144.9

138

WZC30

NOMESCO Finland

Teaching

4.3

136.3

569

1534

322

Kela drug reimbursment

Sunitinib

+∞

135.4

129

N02AX02

ATC

tramadol; systemic, rectal

2.6

134.2

1631

9308

116

Kela drug reimbursment

Prostate cancer

+∞

133.2

127

WX402

NOMESCO Finland

General anaesthesia

3.8

131.8

645

2001

180

Kela drug reimbursment

Interferon alfa

+∞

130.1

124

N02AA05

ATC

oxycodone; systemic

3.7

129.4

645

2030

L01XE26

ATC

[U] cabozantinib; oral

+∞

129.0

123

L01XE11

ATC

[U] pazopanib; oral

+∞

121.6

116

KA1AE

NOMESCO Finland

Kidney ultrasound examination

10.8

117.4

235

234

8000/3-C64.9

ICD-O-3

Neoplasm, malignant of kidney, NOS

+∞

113.2

108

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

8.1

113.0

268

359

WF002

NOMESCO Finland

Radical radiotherapy

77.9

112.2

127

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

8.4

111.7

258

331

1890B

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]

+∞

111.1

106

L01EX07

ATC

cabozantinib; oral

+∞

109.0

104

158

Kela drug reimbursment

Everolimus

+∞

104.7

100

JN3AD

NOMESCO Finland

Abdominal CT examination

4.4

102.3

402

1004

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

258.0

98.2

100

115

Kela drug reimbursment

Breast cancer

+∞

95.3

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

94.2

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

54.7

93.1

111

PJA12

NOMESCO Finland

Sentinel node biopsy

460.4

90.7

R31

ICD-10 Finland

Unspecified haematuria

3.3

90.4

527

1827

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.8

87.4

405

1169

UKC02

NOMESCO Finland

Cystoscopy

2.7

87.3

716

3101

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

10.4

87.2

177

180

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

85.8

NK6AN

NOMESCO Finland

Total body bone isotope imaging

67.3

85.0

N02BE01

ATC

paracetamol; systemic, rectal

2.5

81.2

2672

21892

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

79.5

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

402.1

79.2

KA3LT

NOMESCO Finland

Njurlesion coagulation

270.5

77.8

A04AA01

ATC

ondansetron; systemic, rectal

8.5

76.5

174

216

ZXC96

NOMESCO Finland

Robot assisted procedure

22.1

75.3

111

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.3

75.1

425

1428

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

259.6

74.7

WF004

NOMESCO Finland

Palliative radiotherapy

745.1

74.5

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

21.3

74.4

111

168

Kela drug reimbursment

Axitinib

+∞

74.2

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.6

73.9

632

2771

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

9.4

73.5

157

175

ZX090

NOMESCO Finland

Other technic of radiotherapy

191.9

72.4

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

83.1

72.3

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

189.2

71.4

R4110

NOMESCO Finland

Physiotherapy

2.2

70.4

902

4838

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

70.0

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

69.7

754

3730

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.9

66.5

298

827

L01XE10

ATC

[U] everolimus; oral

+∞

65.8

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

65.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.5

65.5

333

1026

L02AE02

ATC

leuprorelin; implant, parenteral

39.6

64.1

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.0

63.8

185

325

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

630.1

63.0

WW500

NOMESCO Finland

Blood transfusion

6.6

62.3

167

265

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

61.6

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.7

61.6

220

491

KAC01

NOMESCO Finland

Percutaneous endoscopic nephrectomy

214.0

61.3

L01BC06

ATC

capecitabine; oral

+∞

60.6

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

110.5

60.0

1890X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]

+∞

59.5

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

59.5

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

58.5

WF003

NOMESCO Finland

Adjuvant radiotherapy

83.0

58.1

343

Kela drug reimbursment

Pazopanib

+∞

57.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

567.7

56.8

C648

ICD-10 Finland

+∞

56.4

L02BB03

ATC

bicalutamide; oral

+∞

55.4

L01XE17

ATC

[U] axitinib; oral

+∞

55.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

546.9

54.7

S18

ICPC

Laceration/cut

1.8

54.4

1318

8856

N18.8

ICD-10 Finland

Other chronic renal failure

4.6

54.0

197

449

U14

ICPC

Kidney symptom/complaint

7.8

53.9

128

170

L03AA13

ATC

pegfilgrastim; parenteral

+∞

53.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

53.0

259

770

Y77

ICPC

Malignant neoplasm prostate

116.0

52.9

C08CA01

ATC

amlodipine; oral

1.8

52.8

1339

9107

198

Kela drug reimbursment

Sorafenib

+∞

51.2

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

137.2

50.9

ZX080

NOMESCO Finland

Image guided radiotherapy

259.3

50.2

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

259.3

50.2

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

50.1

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

50.1

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

176.0

50.0

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.7

49.8

232

662

GD1AD

NOMESCO Finland

Thorax CT examination

4.1

49.5

202

513

L01EX01

ATC

sunitinib; oral

+∞

49.1

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

8.4

48.5

109

133

ZX070

NOMESCO Finland

Intensity modified radiotherapy

484.8

48.5

SPAT1153

SPAT

Removal of sutures

1.8

46.5

1013

6474

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

11.0

45.5

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

30.5

44.9

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

49.9

44.9

8960/3-C64.9

ICD-O-3

Nephroblastoma, NOS, of kidney, NOS

+∞

44.9

340

Kela drug reimbursment

Everolimus

+∞

44.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.6

44.6

354

1456

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

12.8

44.0

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.7

43.6

155

344

L03AA02

ATC

filgrastim; parenteral

42.2

43.5

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

433.2

43.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

42.8

KCD02

NOMESCO Finland

Transurethral resection of bladder

18.7

42.7

ZX120

NOMESCO Finland

Intravenous

2.8

42.6

292

1099

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

42.3

401

1812

A79

ICPC

Malignancy NOS

79.5

41.9

A11CC03

ATC

alfacalcidol; systemic

4.7

41.9

147

322

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

41.7

XKD00

NOMESCO Finland

Uroflowmetry

2.0

41.7

599

3265

L02BG04

ATC

letrozole; oral

22.6

41.4

TK800

NOMESCO Finland

Hemodialysis

4.7

40.3

142

312

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

39.6

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

8.2

39.4

113

C50.99

ICD-10 Finland

Breast, unspecified

392.0

39.1

ZXA05

NOMESCO Finland

Left side

1.8

39.0

856

5416

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.3

39.0

150

360

HAC20

NOMESCO Finland

Total mastectomy

87.2

38.8

R50.9

ICD-10 Finland

Fever, unspecified

2.2

38.8

430

2090

361

Kela drug reimbursment

Axitinib

+∞

38.6

L01XE05

ATC

[U] sorafenib; oral

+∞

38.6

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

38.6

M04AA01

ATC

allopurinol; systemic

2.0

38.4

556

3029

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.8

38.2

147

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

17.4

38.0

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

37.8

485

2513

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

37.6

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.4

37.3

139

324

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

16.5

37.2

M05BX04

ATC

denosumab; parenteral

3.6

37.1

174

499

WX704

NOMESCO Finland

Intubation

2.8

36.7

245

906

WX110

NOMESCO Finland

Local anesthesy

1.6

36.2

1800

14263

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

22.0

35.7

HA1AA

NOMESCO Finland

X-ray mammography

5.6

35.5

107

198

PHE70

NOMESCO Finland

Thrombectomy of inferior vena cava

+∞

35.5

L03AA04

ATC

67.4

35.0

J01MA02

ATC

ciprofloxacin; systemic

1.6

34.7

1194

8558

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

12.6

34.5

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

7.9

34.4

104

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

6.4

33.8

146

V03AE01

ATC

polystyrene sulfonate; oral

6.2

33.6

151

1890A

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]

+∞

33.4

205

Kela drug reimbursment

Chronic hypertension

1.6

33.3

1103

7801

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

330.3

32.9

J01MA12

ATC

levofloxacin; systemic

1.9

32.8

576

3354

KA4AT

NOMESCO Finland

Cytology of kidney with ultrasound guidance

117.9

32.7

HAB40

NOMESCO Finland

Wedge excision of mammary gland

21.2

32.6

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

32.3

BCA30

NOMESCO Finland

Unilateral adrenalectomy

40.5

32.1

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

31.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

31.3

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

31.3

ZXA00

NOMESCO Finland

Right side

1.7

31.2

872

5862

JN6AD

NOMESCO Finland

CT of torso and neck

17.1

31.0

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

25.6

31.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

30.9

530

3054

C03CA01

ATC

furosemide; systemic

1.6

30.8

1084

7750

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

30.2

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

30.2

18900

ICD-8 Finland

Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis

+∞

30.2

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

30.2

A02BC02

ATC

pantoprazole; systemic

1.5

30.2

1855

15144

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

30.2

913

6261

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

305.0

29.8

L03AB05

ATC

interferon alfa-2b; parenteral

34.9

29.6

R4190

NOMESCO Finland

Nutritional therapy

5.1

29.4

187

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

29.2

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

29.2

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

9.3

29.1

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

29.0

173

593

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

7.4

28.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

28.5

1965

16369

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

28.2

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

28.2

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

28.2

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.0

28.1

166

564

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

31.2

28.1

A12AA04

ATC

calcium carbonate; oral

4.7

28.0

211

Z85.5

ICD-10 Finland

Personal history of malignant neoplasm of urinary tract

283.8

27.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

27.6

195

743

B03XA02

ATC

darbepoetin alfa; parenteral

4.8

27.5

197

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.6

27.4

109

N28.1

ICD-10 Finland

Cyst of kidney

5.0

27.2

182

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

27.1

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

27.1

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.8

26.8

194

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.8

26.6

195

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

26.1

8010/3-C64.9

ICD-O-3

Carcinoma, NOS, of kidney, NOS

+∞

26.1

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.8

25.9

129

Z51.0

ICD-10 Finland

Radiotherapy session

262.5

25.7

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

136.0

25.6

L02BA01

ATC

tamoxifen; oral

33.3

25.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

25.5

537

3291

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

25.0

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

24.9

852

5975

A04AD12

ATC

aprepitant; systemic

251.9

24.7

KB1CG

NOMESCO Finland

Extensive MRI examination of urinary tract with high intensity magnet

251.9

24.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

131.0

24.6

L03AB04

ATC

interferon alfa-2a; parenteral

27.7

24.4

Z31.5

ICD-10 Finland

Genetic counselling

3.9

24.1

101

264

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.0

24.0

144

496

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

24.0

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

24.0

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

24.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

24.0

L01EX03

ATC

pazopanib; oral

+∞

24.0

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

87.4

23.7

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.9

23.5

113

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.0

23.2

140

485

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

54.4

23.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

22.9

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

22.9

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

22.9

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

22.9

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.7

22.8

168

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

120.8

22.6

C50

ICD-10 Finland

Malignant neoplasm of breast

120.8

22.6

J01DB01

ATC

cefalexin; oral

1.5

22.5

2262

19851

N18.0

ICD-10 Finland

End-stage renal disease

4.7

22.3

163

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

27.5

22.2

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

24.0

22.1

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

19.6

22.1

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

21.9

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

21.9

UJF32

NOMESCO Finland

Coloscopy

1.6

21.7

707

4870

PC5DT

NOMESCO Finland

Embolisation of tumor of kidney

80.6

21.7

2395A

ICD-9 Finland

Neoplasm of unspecified nature, Other genito-urinary organs

20.2

21.7

TQW99

NOMESCO Finland

Other minor procedure on skin

3.1

21.5

123

411

Z90.5

ICD-10 Finland

Acquired absence of kidney

43.6

21.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.1

21.4

213

WX725

NOMESCO Finland

Noninvasive ventilation

2.6

21.2

155

606

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

20.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

20.6

230

1112

KA3CT

NOMESCO Finland

Biopsy of kidney under CT guidance

211.2

20.6

A04AA55

ATC

palonosetron, combinations; systemic

211.2

20.6

C90.0

ICD-10 Finland

Multiple myeloma

110.7

20.6

KH1AD

NOMESCO Finland

CT of urinary organs

3.0

20.5

119

402

G04CA02

ATC

tamsulosin; oral

1.5

20.5

869

6351

JMA10

NOMESCO Finland

Transabdominal total splenectomy

22.5

20.4

B01AB04

ATC

dalteparin; parenteral

2.6

20.3

155

620

A06AH03

ATC

naloxegol; oral

11.0

20.1

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

27.2

20.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

19.8

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

19.8

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

19.8

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

19.8

PHN71

NOMESCO Finland

Excision of tumor mass from inferior vena cava

+∞

19.8

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

73.9

19.7

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

105.6

19.6

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

201.1

19.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

40.3

19.5

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

19.3

283

1527

C02AC05

ATC

moxonidine; oral

2.3

19.2

182

816

D41.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified

46.3

19.2

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.7

19.0

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

18.9

184

835

137

Kela drug reimbursment

Uraemia requiring dialysis

6.1

18.9

A06AD11

ATC

lactulose; oral

1.7

18.8

463

2953

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

18.8

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

18.8

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

18.8

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

18.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

18.8

L01EK01

ATC

axitinib; oral

+∞

18.8

128

Kela drug reimbursment

Cancers of female genital organs

+∞

18.8

GDC00

NOMESCO Finland

Lobectomy of lung

70.2

18.7

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

100.6

18.6

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

12.9

18.4

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

18.4

150

624

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

18.3

402

2476

U06

ICPC

Haematuria

3.4

18.3

266

ZX050

NOMESCO Finland

Stereotactic radiotherapy

33.1

17.9

H05BX01

ATC

cinacalcet; oral

8.4

17.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.6

17.8

229

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.8

17.8

118

435

N02AA01

ATC

morphine; systemic, rectal

5.5

17.8

Z94.0

ICD-10 Finland

Kidney transplant status

5.5

17.8

RJ128

NOMESCO Finland

18.1

17.8

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

17.7

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

66.9

17.7

V03AE02

ATC

sevelamer; oral

10.4

17.6

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.8

17.6

118

439

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

95.5

17.6

ZX112

NOMESCO Finland

Subcutaneous

6.7

17.5

U79

ICPC

Neoplasm urinary tract unspecified

180.8

17.5

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

180.8

17.5

ZZR00

NOMESCO Finland

Flap of skin

6.9

17.4

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

13.1

17.4

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

17.4

188

895

JLC10

NOMESCO Finland

Distal pancreatectomy

42.2

17.3

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.5

17.1

134

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

17.1

804

5964

OAB42

NOMESCO Finland

Guidance related to known health problem

25.7

16.9

D70.82

ICD-10 Finland

Drug-induced neutropenia

10.1

16.9

M05BA02

ATC

clodronic acid; systemic

63.6

16.7

M907, C6488

ICD-10 Finland

+∞

16.7

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

16.7

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

16.7

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

16.7

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

5.9

16.6

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

90.5

16.6

JFB30

NOMESCO Finland

Right hemicolectomy

7.3

16.5

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

16.4

330

1981

WX290

NOMESCO Finland

Other blockade of nerve

1.4

16.3

912

6990

C08CA02

ATC

felodipine; oral

1.7

16.1

338

2052

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.0

16.0

158

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

15.6

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

15.6

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

15.6

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

15.6

E83.50

ICD-10 Finland

Hypercalcemia

4.8

15.5

107

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.8

15.5

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

4.6

15.5

116

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

160.6

15.5

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

160.6

15.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

160.6

15.5

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

15.4

199

1023

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

15.3

267

1527

JAH00

NOMESCO Finland

Laparotomy

3.1

15.3

276

196

Kela drug reimbursment

Paricalcitol and cinacalcet

8.7

15.2

B05DA

ATC

Isotonic solutions

6.2

15.1

R33

ICD-10 Finland

Retention of urine

1.8

15.1

272

1574

127

Kela drug reimbursment

Transplant complication

4.3

15.1

129

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

45.2

15.0

C08CA13

ATC

lercanidipine; oral

1.6

15.0

415

2720

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

14.9

140

627

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.3

14.9

226

B02AA02

ATC

tranexamic acid; systemic

1.8

14.8

268

1552

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.7

14.6

102

388

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

14.6

L02BX02

ATC

degarelix; parenteral

+∞

14.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

14.6

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

14.6

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

14.6

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

14.6

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

14.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

14.6

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

14.6

J01EA01

ATC

trimethoprim; systemic

1.5

14.5

582

4160

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

36.2

14.4

N03AX16

ATC

pregabalin; oral

1.5

14.4

598

4306

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

12.6

14.4

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

27.3

14.3

XW000

NOMESCO Finland

Bone marrow biopsy

2.7

14.2

100

383

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

14.2

290

1745

WW200

SPAT

0.4

14.2

1654

321

Kela drug reimbursment

Paricalcitol and cinacalcet

7.2

14.0

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.0

13.9

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

5.0

13.9

WX892

NOMESCO Finland

Monitored bed care

1.8

13.9

228

1277

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.4

13.9

121

521

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.3

13.7

208

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.9

13.6

L01EG02

ATC

everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))

+∞

13.5

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

13.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

13.5

C68.9

ICD-10 Finland

Malignant neoplasm: Urinary organ, unspecified

+∞

13.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

140.5

13.4

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

8.8

13.4

L04AA06

ATC

mycophenolic acid; systemic

3.7

13.4

154

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

13.4

508

3580

KC1GB

NOMESCO Finland

Cystography with X-ray

25.8

13.3

H02AB06

ATC

prednisolone; systemic

1.3

13.3

1253

10401

B03XA01

ATC

erythropoietin; parenteral

4.8

13.2

A10BH05

ATC

linagliptin; oral

2.0

13.2

176

917

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

8.5

13.2

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

15.1

13.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

13.1

200

1094

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.9

13.0

202

1114

WX600

NOMESCO Finland

Single shot through catheter

8.3

13.0

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

13.0

298

1855

P01AB01

ATC

metronidazole; oral, rectal

1.4

12.9

906

7172

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

12.9

899

7110

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

50.2

12.8

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.5

12.8

E87.5

ICD-10 Finland

Hyperkalaemia

3.0

12.7

248

PC5SC

NOMESCO Finland

Selective angiography of kidney artery with X-ray

32.1

12.6

GDB10

NOMESCO Finland

Wedge resection of lung

32.1

12.6

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

32.1

12.6

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

12.5

216

1232

WX882

NOMESCO Finland

High dependency care

2.6

12.5

368

Z49.2

ICD-10 Finland

Other dialysis

5.5

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

12.5

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

12.5

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

+∞

12.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

12.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

12.5

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

+∞

12.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

12.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

12.5

N99.0

ICD-10 Finland

Postprocedural renal failure

24.4

12.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

130.4

12.4

D41

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of urinary organs

130.4

12.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

130.4

12.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

130.4

12.4

L02AE04

ATC

triptorelin; parenteral

130.4

12.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

130.4

12.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

130.4

12.4

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.3

12.4

192

N05CF01

ATC

zopiclone; oral

1.4

12.4

886

7025

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

12.3

271

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

12.3

174

927

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.4

12.2

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

26.8

12.0

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.4

11.8

XX9XW

NOMESCO Finland

6.3

11.7

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

30.1

11.6

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.6

11.6

148

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

5.4

11.6

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

12.6

11.6

L57.0

ICD-10 Finland

Actinic keratosis

1.8

11.6

217

1272

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

65.1

11.6

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.6

11.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

11.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

11.5

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

+∞

11.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

11.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

11.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

11.5

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

11.5

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

11.5

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

11.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

11.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

11.5

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

11.5

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

11.5

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

11.4

264

1648

G04BE03

ATC

sildenafil; oral

6.3

11.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

11.3

1175

9825

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.9

11.2

117

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

9.6

11.2

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

9.6

11.2

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

7.3

11.2

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

11.2

279

1777

JAH01

NOMESCO Finland

Laparoscopy

2.6

11.2

325

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

5.3

11.2

J01CA04

ATC

amoxicillin; systemic

1.3

11.2

2085

18880

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

25.1

11.1

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.8

11.1

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

8.0

11.1

B05DB

ATC

Hypertonic solutions

5.6

11.0

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

10.9

197

1141

X76

ICPC

Malignant neoplasm breast female

43.4

10.9

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.2

10.9

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.2

10.9

173

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

6.1

10.7

GDA20

NOMESCO Finland

Excision of lesion of lung

21.5

10.7

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12.9

10.6

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

4.1

10.6

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

8.0

10.6

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

10.6

706

5510

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

4.8

10.5

E0000UV

ATC

1.3

10.5

920

7485

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

10.5

1164

9797

H02AB09

ATC

hydrocortisone; systemic

3.0

10.4

205

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

110.3

10.4

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

10.4

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

10.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

10.4

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

10.4

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

10.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

10.4

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

10.4

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

10.4

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

10.4

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

10.4

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

10.4

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

10.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

10.4

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

10.4

141

741

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

7.7

10.4

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

8.2

10.3

TK820

NOMESCO Finland

Peritoneal dialysis

6.4

10.3

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.9

10.3

107

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.8

10.3

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

9.6

10.2

WF099

NOMESCO Finland

Other radiotherapy

23.4

10.2

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

6.6

10.2

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.8

10.1

113

C07AB02

ATC

metoprolol; systemic

1.4

10.0

673

5253

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

4.0

10.0

C09AA02

ATC

enalapril; systemic

1.4

10.0

647

5023

N19

ICD-10 Finland

Unspecified kidney failure

2.1

9.9

116

576

J94.8

ICD-10 Finland

Other specified pleural conditions

3.1

9.8

164

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

9.8

107

517

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

9.8

249

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

26.1

9.8

L02BG03

ATC

anastrozole; oral

20.1

9.8

7124

FHL

Nephrectomy (simple

20.1

9.8

D75

ICPC

Malignant neoplasm colon/rectum

20.1

9.8

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

9.7

457

3349

105

Kela drug reimbursment

Adrenal cortical hypofunction

13.4

9.7

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

13.4

9.7

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

55.1

9.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

9.6

105

507

N18

ICD-10 Finland

Chronic kidney disease

3.3

9.6

140

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

9.6

381

2703

N43.3

ICD-10 Finland

Hydrocele, unspecified

2.6

9.6

265

KEB00

NOMESCO Finland

Biopsy of prostate

5.0

9.5

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

10.0

9.5

JLC30

NOMESCO Finland

Pancreatoduodenectomy

15.0

9.5

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

100.3

9.4

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

100.3

9.4

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

30.1

9.4

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

+∞

9.4

PHN70

NOMESCO Finland

Plastic repair of inferior vena cava

+∞

9.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

9.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

9.4

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

9.4

PJD99

NOMESCO Finland

Excision of other lymph nodes

+∞

9.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

9.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

9.4

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

9.4

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

9.4

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

9.4

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

9.4

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

9.4

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.4

9.4

132

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

6.2

9.4

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

12.4

9.3

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

9.3

485

3618

M10.9

ICD-10 Finland

Gout, unspecified

1.6

9.2

221

1390

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.4

9.2

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

5.7

9.2

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

9.2

115

588

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

9.1

335

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

9.1

342

2397

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.9

9.1

N06DX01

ATC

memantine; oral

0.5

9.1

1425

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.8

9.1

206

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.2

9.0

H03AA01

ATC

levothyroxine sodium; systemic

1.4

9.0

523

3982

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.6

8.9

106

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

6.1

8.9

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.3

8.9

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

8.8

449

C09BA02

ATC

enalapril and diuretics; systemic

1.5

8.8

277

1870

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

9.5

8.8

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

14.0

8.7

ZX121

NOMESCO Finland

Central venous catheter

14.0

8.7

D77

ICPC

Malignant digestive neopl other/NOS

50.1

8.7

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

50.1

8.7

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.8

8.6

186

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

8.6

106

538

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

5.8

8.6

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.9

8.5

169

A07AA02

ATC

nystatin; oral

1.8

8.5

147

845

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.3

8.5

312

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

27.6

8.5

R84

ICPC

Malignant neoplasm bronchus/lung

27.6

8.5

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.1

8.4

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

90.2

8.4

ZXC50

NOMESCO Finland

Cryotherapy

2.5

8.4

250

212

Kela drug reimbursment

Gout

2.3

8.4

327

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

12.8

8.4

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

8.3

1891X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]

+∞

8.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

8.3

L02BG06

ATC

exemestane; oral

+∞

8.3

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

8.3

Q85.82

ICD-10 Finland

of Hipple-Lindau syndrome

+∞

8.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

8.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

8.3

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

8.3

9680/3-C64.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of kidney, NOS

+∞

8.3

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

8.3

1CD02

NOMESCO Finland

+∞

8.3

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

+∞

8.3

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

+∞

8.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

8.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

8.3

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

8.3

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

8.3

ZXC20

NOMESCO Finland

Use of chemical agents

3.1

8.3

145

SPAT1254

SPAT

Administration of medicine

1.4

8.3

389

2848

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

8.5

8.3

JAL30

NOMESCO Finland

Omentectomy

10.8

8.3

R11

ICD-10 Finland

Nausea and vomiting

1.7

8.1

166

1002

JFB43

NOMESCO Finland

Left hemicolectomy

6.0

8.1

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.6

8.1

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.3

8.1

115

KB1DG

NOMESCO Finland

Very extensive MRI of urinary tract

33.4

8.1

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

33.4

8.1

TKE10

NOMESCO Finland

Puncture of prostate

33.4

8.1

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

8.1

Q60.0

ICD-10 Finland

Renal agenesis, unilateral

17.2

8.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

8.1

470

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

22.1

8.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

8.0

917

7685

KED22

NOMESCO Finland

Transurethral resection of prostate

1.6

8.0

189

1189

WX002

NOMESCO Finland

Sedation and analgesia

1.4

8.0

503

3876

ZX100

NOMESCO Finland

Oral

3.4

8.0

106

C07AB07

ATC

bisoprolol; oral

1.2

7.9

1452

12847

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.6

7.9

TPX15

NOMESCO Finland

Removal of vascular injection port

7.8

7.9

WX610

NOMESCO Finland

Patient controlled analgesia

7.8

7.9

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

7.8

7.9

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.2

7.9

118

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.5

7.8

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

7.8

175

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.4

7.8

108

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.6

7.8

210

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

10.8

7.8

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

10.8

7.8

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

6.9

7.8

N06DA02

ATC

donepezil; oral

0.5

7.7

1265

Z80.5

ICD-10 Finland

Family history of malignant neoplasm of urinary tract

45.0

7.7

XX1XN

NOMESCO Finland

Other isotope examination

45.0

7.7

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

45.0

7.7

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

45.0

7.7

BAA60

NOMESCO Finland

Total thyroidectomy

3.1

7.7

131

N05BA04

ATC

oxazepam; oral

1.3

7.7

572

4520

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.7

352

2568

SPAT1262

SPAT

Handing over of treatment supplies

1.3

7.6

495

3828

K65.0

ICD-10 Finland

Acute peritonitis

3.4

7.6

105

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.9

7.6

111

604

PC5NT

NOMESCO Finland

Endovascular embolisation for kidney bleeding with radiological guidance

80.2

7.4

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

80.2

7.4

XX1AD

NOMESCO Finland

Other CT-examination

80.2

7.4

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.0

7.4

Z93.3

ICD-10 Finland

Colostomy status

7.6

7.4

DAB00

NOMESCO Finland

Excision of lesion of auricle

5.3

7.4

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.8

7.3

C09CA01

ATC

losartan; oral

1.3

7.3

680

5534

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

7.3

PHC70

NOMESCO Finland

Suture of inferior vena cava

+∞

7.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

7.3

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

7.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

7.3

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

7.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

7.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

7.3

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

M90.7

ICD-10 Finland

Fracture of bone in neoplastic disease

+∞

7.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

7.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

7.3

390

Kela drug reimbursment

Ibrutinib

+∞

7.3

5BX04

NOMESCO Finland

+∞

7.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

7.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

7.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

7.3

L01CA04

ATC

vinorelbine; systemic

+∞

7.3

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

7.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

7.3

1XC17

NOMESCO Finland

+∞

7.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

7.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

7.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

7.3

XX6LT

NOMESCO Finland

Coagulation of tumour with radiological guidance

+∞

7.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

7.3

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

7.3

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

6.8

7.3

XF612

NOMESCO Finland

Measurement of central venous pressure

9.4

7.3

KCB00

NOMESCO Finland

Biopsy of bladder

9.4

7.3

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

9.4

7.3

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.0

7.2

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.2

288

2043

ZZA50

NOMESCO Finland

Full thickness skin graft

15.8

7.2

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

15.8

7.2

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

7.3

7.2

KWW96

NOMESCO Finland

Other reoperation in urological surgery

30.0

7.1

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

30.0

7.1

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.7

7.1

A10AE04

ATC

insulin glargine; parenteral

1.5

7.1

263

1836

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.7

7.1

172

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

4.8

7.1

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.8

7.1

156

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.0

7.1

128

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

7.1

127

740

TGD00

NOMESCO Finland

Needle biopsy of lung

12.0

7.1

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

7.0

245

1691

S15

ICPC

Foreign body in skin

1.7

7.0

147

894

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

10.0

7.0

AA1AD

NOMESCO Finland

CT of head and brain

1.3

7.0

669

5463

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.6

6.9

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.1

6.9

357

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

6.9

136

815

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

5.1

6.9

R04.2

ICD-10 Finland

Haemoptysis

1.9

6.9

536

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.3

6.8

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.7

6.8

164

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

3.0

6.8

126

A12BA01

ATC

potassium chloride; oral

1.7

6.8

147

906

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

6.7

6.8

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.9

6.8

135

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

4.2

6.8

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

6.8

175

1127

TK810

NOMESCO Finland

Hemofiltration

4.0

6.8

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.3

6.8

7121

FHL

Removal of local change or renal resection (eg cyst)

40.1

6.8

ZX022

NOMESCO Finland

LDR radiotherapy within tissue

40.1

6.8

1530

FHL

Urethrocystoscopy

2.3

6.7

247

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

16.7

6.7

JN3BG

NOMESCO Finland

MRI examination of abdomen with high intensity magnet

16.7

6.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

6.7

170

1090

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.3

6.7

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.5

6.7

199

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

2.8

6.7

144

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

6.7

257

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

5.2

6.6

R06.0

ICD-10 Finland

Dyspnoea

1.3

6.6

656

5378

A46

ICD-10 Finland

Erysipelas

1.4

6.6

387

2944

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.2

6.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

6.5

561

4513

L02AE03

ATC

goserelin; implant

8.7

6.5

A02BC01

ATC

omeprazole; systemic

1.3

6.5

716

5940

3AC01

NOMESCO Finland

3.3

6.5

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

6.5

353

2650

K92.1

ICD-10 Finland

Melaena

1.7

6.5

139

855

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

6.5

1014

L04AD01

ATC

ciclosporin; systemic

2.6

6.5

166

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

3.8

6.5

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.5

6.4

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.7

6.4

KFC10

NOMESCO Finland

Bilateral orchiectomy

69.9

6.4

WX1BG

NOMESCO Finland

Total body MRI with high intensity magnet

69.9

6.4

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.6

6.4

167

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.3

6.4

EB1WA

NOMESCO Finland

4.7

6.4

R60.0

ICD-10 Finland

Localized oedema

1.4

6.4

278

2010

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.7

6.4

N20.1

ICD-10 Finland

Calculus of ureter

1.8

6.3

106

607

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.1

6.3

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.4

6.3

206

KBV10

NOMESCO Finland

Removal of stent from ureter

4.2

6.3

306

Kela drug reimbursment

Erythropoietin and darbepoetin

5.9

6.3

3025

Kela drug reimbursment

Calcium carbonate

5.9

6.3

J01MA14

ATC

moxifloxacin; systemic

1.5

6.3

207

1411

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

11.0

6.3

WX250

NOMESCO Finland

Intercostal blockade

9.3

6.3

JG1CG

NOMESCO Finland

Extensive MRI of rectum

18.0

6.3

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

18.0

6.3

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.8

6.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

6.2

C68

ICD-10 Finland

Malignant neoplasm of other and unspecified urinary organs

+∞

6.2

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

6.2

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.2

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

6.2

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

6.2

1899X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Urinary organ, site unspecified[NEOPLASMA MAL ORG URIN NUD,EI HIST VAHV]

+∞

6.2

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

+∞

6.2

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

6.2

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

+∞

6.2

L01CB01

ATC

etoposide; systemic

+∞

6.2

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

6.2

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

6.2

1890C

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,MUU/TARK MÄÄR SYÖPÄ]

+∞

6.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

6.2

8890/3-C64.9

ICD-O-3

Leiomyosarcoma, NOS, of kidney, NOS

+∞

6.2

WE198

NOMESCO Finland

Palliative cystotatic therapy

+∞

6.2

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

6.2

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

6.2

L01AX03

ATC

temozolomide; systemic

+∞

6.2

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

6.2

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

6.2

8316/3-C64.9

ICD-O-3

Cyst-associated renal cell carcinoma of kidney, NOS

+∞

6.2

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

6.2

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

6.2

KAC96

NOMESCO Finland

Other nephrectomy

+∞

6.2

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

6.2

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

+∞

6.2

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

6.2

KAD10

NOMESCO Finland

Heminephrectomy

+∞

6.2

7126

FHL

Nephroureterectomy

+∞

6.2

8318/3-C64.9

ICD-O-3

Renal cell carcinoma, sarcomatoid of kidney, NOS

+∞

6.2

323

Kela drug reimbursment

Sorafenib

+∞

6.2

PC5ET

NOMESCO Finland

Extensive embolisation of tumor of kidney

+∞

6.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

6.2

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

+∞

6.2

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

6.2

L01XE27

ATC

[U] ibrutinib; oral

+∞

6.2

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

6.2

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.2

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

6.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

6.2

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

6.2

HA1HA

NOMESCO Finland

Tomosynthesis mammography

26.7

6.2

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

26.7

6.2

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

7.0

6.2

KA3EB

NOMESCO Finland

Antegrade pyelography

7.0

6.2

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

6.2

221

JFB00

NOMESCO Finland

Partial resection of small intestine

2.8

6.1

129

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

6.0

119

713

KDE20

NOMESCO Finland

Removal of foreign body from urethra

4.9

6.0

ZYC01

SPAT

0.5

6.0

718

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

3.4

6.0

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

6.0

335

2527

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

821

887

11.34

307.65

1.4

1.2

—

(3037121) Protein [Mass/volume] in Urine

607

1076

6.45

307.65

3.0

2.8

0.3

g/l

1.21

408

392

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2525

13297

3.37

304.57

5.0

3.7

—

(3044640) Blood type and Crossmatch panel - Blood

1893

8780

3.16

276.52

3.0

2.3

—

(40768804) Tissue Pathology biopsy report

1960

9376

3.10

269.43

2.5

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2424

13395

3.00

250.97

7.9

3.9

34.2

35.3

g/l

15.88

2296

12209

(3020779) Urea [Moles/volume] in Serum or Plasma

944

3056

3.72

244.15

9.2

7.1

11.4

11.2

mmol/l

0.52

899

2884

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

988

3338

3.59

239.01

4.3

2.8

233.9

240.6

u/l

0.80

964

3091

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

663

1749

4.33

227.79

7.8

10.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

945

3240

3.50

221.93

7.5

7.6

119.7

122.4

g/l

3.69

925

3118

(3002582) Erythrocytes [#/volume] in Urine

1896

9701

2.79

217.94

4.8

3.1

76.3

91.6

e6/l

0.28

1584

7408

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2476

14512

2.80

217.63

10.4

5.5

1.2

mmol/l

0.35

2338

12827

(3000991) Gas panel - Venous blood

846

2754

3.62

214.73

9.3

7.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2549

15235

2.80

214.33

11.3

3.9

10.9

12.5

umol/l

6.95

2459

14226

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1083

4143

3.20

211.59

9.1

5.7

1.1

1.0

mmol/l

3.89

1020

3795

(3016502) Oxygen saturation in Arterial blood

994

3616

3.31

211.22

7.2

7.1

96.6

95.0

16.88

964

3477

(3014576) Chloride [Moles/volume] in Serum or Plasma

1079

4173

3.16

206.32

8.4

6.4

104.8

104.3

mmol/l

2.53

1064

4060

(3030467) Casts [#/volume] in Urine by Automated count

1765

8894

2.74

206.29

4.6

3.0

0.3

0.5

e6/l

1.53

1450

6658

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1471

6751

2.85

206.22

2.9

2.2

—

(3003396) Base excess in Arterial blood by calculation

1037

3952

3.18

202.99

7.2

6.9

-0.2

1.2

mmol/l

25.63

843

3035

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

633

1758

4.08

201.64

3.0

1.4

14.4

10.5

ug/l

0.19

510

1314

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1036

3980

3.15

199.67

7.2

6.8

5.3

5.0

kpa

14.69

1004

3790

(3027801) Oxygen [Partial pressure] in Arterial blood

1035

3979

3.15

199.18

7.2

6.8

13.7

11.5

kpa

29.59

1001

3783

(36304419) Bacteria [Presence] in Urine

1680

8519

2.65

190.37

4.6

3.0

—

(3002256) Pathology report gross observation

722

2287

3.62

189.41

1.4

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

600

1702

3.96

184.79

8.4

8.9

23.4

24.4

mmol/l

11.99

578

1551

(3031040) Bacteria [#/volume] in Urine by Automated count

3020

20515

2.83

183.72

6.0

4.4

606.2

2237.8

e6/l

1.87

335

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2554

16054

2.59

180.98

12.0

5.9

1.2

mmol/l

0.91

2165

13461

(3018095) Leukocytes [#/volume] in Urine

1990

11176

2.53

179.11

5.5

3.5

64.8

105.0

e6/l

2.10

1632

7967

(3000850) Epithelial cells [#/volume] in Urine

1403

6761

2.64

173.15

3.5

2.5

3.5

4.4

e6/l

3.19

1272

5855

(3023368) Bacteria identified in Blood by Culture

1704

9032

2.52

171.91

5.3

3.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3275

23717

2.95

166.52

14.0

5.4

83.4

76.9

u/l

13.41

3182

21871

(3026782) Osmolality of Urine

1313

6249

2.63

164.85

3.9

2.6

541.3

557.8

mosm/kgh2o

2.24

1171

5224

(3013650) Neutrophils [#/volume] in Blood by Automated count

2556

16590

2.45

160.72

13.9

6.2

4.4

e9/l

0.21

2250

14176

(3032080) INR in Blood by Coagulation assay

2240

13844

2.37

155.53

10.9

11.1

1.2

1.4

inr

9.59

623

3792

(3014111) Lactate [Moles/volume] in Serum or Plasma

777

2920

3.05

151.77

7.7

6.4

1.2

1.4

mmol/l

12.03

757

2793

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1050

4672

2.68

149.01

4.7

2.6

0.8

mmol/l

2.67

1003

4270

(3015377) Calcium [Moles/volume] in Serum or Plasma

1753

9921

2.35

146.96

6.4

2.1

2.4

mmol/l

3.33

1584

8196

(3013826) Glucose [Moles/volume] in Serum or Plasma

2774

19133

2.41

145.05

7.1

4.5

6.9

mmol/l

0.03

2690

17874

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1085

5036

2.57

140.14

4.2

2.8

1.8

2.0

e6/l

0.36

658

2763

(3018418) pH of Serum or Plasma

1640

9198

2.31

138.38

7.6

3.4

7.4

6.82

366

1607

(3035637) Corticotropin [Mass/volume] in Plasma

197

279

7.37

132.48

1.6

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1126

5494

2.45

129.21

3.9

2.6

0.8

1.2

e6/l

3.77

696

3202

(3033658) Prothrombin time (PT) actual/Normal

1374

7351

2.31

127.43

5.5

3.6

90.3

84.4

13.21

1352

7156

(3049717) Cytology report of Urine Cyto stain

404

1152

3.78

121.60

2.5

1.8

—

(3026008) Bacteria identified in Urine by Culture

1601

9382

2.16

116.34

3.4

3.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

2930

21720

2.24

113.85

6.1

4.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

266

633

4.43

102.16

2.7

1.8

10841.0

107.0

u/ml

0.58

230

502

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1019

5215

2.27

101.36

2.2

2.0

30.2

30.1

0.22

1008

5052

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

622

2540

2.71

101.20

6.0

3.9

131.0

97.6

ng/l

7.93

550

2135

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1607

9866

2.04

99.19

4.1

2.3

68.5

60.0

u/l

1.47

1515

9036

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1068

5725

2.17

93.72

5.7

2.2

2.5

2.4

mmol/l

15.61

972

4862

(3004789) Transferrin [Mass/volume] in Serum or Plasma

932

4792

2.23

90.36

3.9

2.6

2.1

2.3

g/l

15.74

878

4408

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

886

4468

2.26

90.04

4.0

2.7

20.1

22.5

6.13

762

3735

(42870588) Differential panel, method unspecified - Blood

1612

10212

1.96

88.33

7.0

5.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

975

5179

2.16

86.66

3.8

2.6

10.7

12.8

umol/l

16.05

914

4748

(3036481) Cortisol [Moles/volume] in Serum or Plasma

578

2501

2.53

82.54

5.1

1.8

394.6

363.9

nmol/l

3.01

552

2251

(3019069) Monocytes/100 leukocytes in Blood

2018

13992

1.88

82.07

7.4

5.9

8.8

8.9

0.87

1914

12882

(3022096) Basophils/100 leukocytes in Blood

1967

13547

1.87

81.52

7.1

5.6

0.6

0.7

2.59

1866

12446

(3002030) Lymphocytes/100 leukocytes in Blood

2042

14294

1.86

79.76

7.2

5.7

24.9

26.8

11.37

1925

13085

(3006504) Eosinophils/100 leukocytes in Blood

2001

13923

1.86

79.63

7.2

5.6

2.9

3.0

1.60

1896

12770

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

336

1110

3.21

79.55

2.9

3.1

0.4

0.3

u/ml

0.78

161

651

(3001604) Monocytes [#/volume] in Blood

2108

14992

1.84

77.36

6.9

5.3

0.6

e9/l

1.12

1814

12774

(3006315) Basophils [#/volume] in Blood

2119

15097

1.84

77.29

6.9

5.3

0.0

e9/l

1.39

1827

12882

(3013115) Eosinophils [#/volume] in Blood

2166

15605

1.83

75.49

7.2

5.5

0.2

e9/l

0.62

1888

13481

(3019198) Lymphocytes [#/volume] in Blood

2143

15395

1.83

75.34

7.0

5.4

1.8

e9/l

0.02

1874

13337

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

179

396

4.68

75.12

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

2005

14138

1.82

74.73

7.0

5.6

59.8

58.0

8.11

1899

13026

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

259

768

3.53

72.76

4.9

3.2

1.8

1.7

mg/l

1.42

237

680

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1413

9169

1.83

67.32

4.6

2.7

32.0

36.3

u/l

1.20

1353

8601

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

527

2393

2.38

66.93

2.0

0.2

g/l

3.45

492

2156

(3003694) ABO and Rh group [Type] in Blood

1190

7338

1.88

66.64

1.4

1.3

—

(40758558) Short blood count panel - Blood

1145

7055

1.87

63.79

10.5

4.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

612

3101

2.15

59.22

3.2

2.2

8.3

umol/l

0.02

545

2657

(3002032) Base excess in Venous blood by calculation

651

3380

2.10

59.10

6.3

3.6

1.2

1.9

mmol/l

4.98

533

2724

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

935

5531

1.90

58.39

1.9

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

573

2863

2.17

57.35

3.0

1.6

65.4

66.7

g/l

3.42

533

2531

(3021447) Carbon dioxide [Partial pressure] in Venous blood

648

3395

2.08

57.29

6.2

3.6

5.8

kpa

0.08

629

3277

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

22.33

57.06

7.9

1.2

—

(3012544) pH of Venous blood

664

3526

2.06

56.55

6.1

3.6

7.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

385

1646

2.48

55.43

7.2

4.0

23.6

24.1

mmol/l

2.38

356

1447

(3009214) Lutropin [Units/volume] in Serum or Plasma

183

541

3.49

51.50

1.5

1.4

15.6

8.0

u/l

5.50

140

443

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

512

2550

2.15

51.34

2.9

2.2

62.0

58.1

u/l

0.04

454

2135

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

457

2185

2.23

50.73

1.8

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

2029

15386

1.64

50.23

5.1

3.7

0.0

estimate

0.50

473

2605

(3009261) Glucose [Presence] in Urine by Test strip

2045

15572

1.63

49.51

5.2

3.7

0.0

estimate

0.02

476

2523

(3021601) Nitrite [Presence] in Urine by Test strip

2012

15399

1.61

46.63

6.8

5.0

0.0

estimate

0.00

483

2650

(1616796) Gas panel - Central venous blood

211

730

2.99

45.79

4.5

3.9

—

(40768800) Prostate Pathology biopsy report

117

274

4.37

45.68

1.2

1.1

—

(3019060) Gas panel - Arterial blood

479

2427

2.10

45.67

4.9

4.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

487

2492

2.08

45.21

2.1

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

462

2324

2.11

44.86

2.0

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1298

9005

1.65

44.38

3.6

2.6

2950.9

5840.4

umol/l

1.93

1129

7635

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

420

3.62

44.31

4.5

5.7

832.9

891.0

iu/ml

0.03

(3027945) Reticulocytes/100 erythrocytes in Blood

684

4006

1.85

42.61

2.7

2.2

1.8

1.7

0.13

621

3480

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

590

3304

1.92

42.22

4.2

3.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

666

3884

1.85

42.01

1.8

1.7

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2788

23400

1.61

41.20

4.9

4.1

18.4

12.6

mm/h

36.01

2577

21414

(3039000) Anion gap in Blood

206

754

2.82

40.32

6.3

7.1

11.2

11.4

mmol/l

0.41

190

677

(3018572) Chloride [Moles/volume] in Blood

206

754

2.82

40.32

6.3

7.1

105.9

104.9

mmol/l

2.94

190

677

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1625

12106

1.57

40.29

3.7

2.8

213.3

145.2

ug/l

11.63

1479

11004

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

658

3883

1.83

39.77

1.8

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

450

2347

2.03

39.41

6.9

24.3

24.5

mmol/l

0.70

428

2179

(3042936) Bacteria identified in Isolate by Culture

723

4413

1.78

38.97

2.2

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

478

2558

1.98

38.91

7.1

3.1

1.2

mmol/l

0.21

446

2172

(3047181) Lactate [Moles/volume] in Blood

253

1056

2.49

38.07

5.8

6.2

1.2

1.3

mmol/l

1.65

229

936

(3021589) Normoblasts [#/volume] in Blood

1746

13346

1.54

37.84

16.1

8.8

0.0

e9/l

0.85

1424

10803

(3003434) Protein [Mass/volume] in Pleural fluid

136

406

3.43

37.70

1.5

32.7

28.5

g/l

3.42

122

354

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1196

8426

1.59

36.99

2.3

3.3

3.0

mg/l

4.29

1028

7113

(3023199) Leukocytes [#/volume] in Pleural fluid

125

361

3.54

36.46

1.5

1488.6

2416.3

e6/l

0.69

262

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

124

360

3.52

35.89

1.6

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

132

400

3.38

35.75

1.6

1.3

0.7

0.6

nmol/l

0.56

127

387

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

293

1343

2.27

35.66

2.0

1.8

1.9

1.8

ug/l

0.11

265

1155

(3012441) Differential panel - Pleural fluid

112

306

3.74

35.48

1.4

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

131

400

3.35

35.05

1.6

1.3

0.2

0.5

nmol/l

1.07

(3023520) Reticulocytes [#/volume] in Blood

527

3011

1.86

35.04

2.9

2.2

66.8

68.2

e9/l

0.39

389

2315

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

415

2190

2.00

35.01

4.6

3.7

1.2

1.8

mmol/l

2.65

295

1575

(3009343) pH of Capillary blood

425

2268

1.98

34.71

4.7

3.8

7.4

1.58

265

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

121

355

3.48

34.47

1.5

1.3

—

nmol/l

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

428

2297

1.96

34.37

4.7

3.8

5.1

kpa

0.38

399

2103

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

140

5.14

34.14

1.3

34.8

29.8

u/l

0.44

102

(40768806) Pleura Pathology biopsy report

105

282

3.80

34.10

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

126

383

3.36

33.96

2.6

1.9

29.3

400.1

u/ml

0.73

113

346

(3012501) Base excess in Blood by calculation

186

717

2.67

32.94

5.1

4.5

2.4

2.6

mmol/l

0.31

125

476

(46235355) HIV 1 and 2 tests - Meaningful Use set

515

2979

1.83

32.79

2.1

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

329

1634

2.10

32.70

1.6

1.9

1.5

g/l

5.38

279

1399

(3028308) Erythrocytes [#/volume] in Pleural fluid

112

324

3.53

32.61

1.4

1.5

79745.3

53001.4

e6/l

0.26

188

(3021879) Hepatitis B virus core Ab [Presence] in Serum

296

1416

2.18

32.40

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

165

609

2.78

31.79

1.3

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

495

2855

1.84

31.76

4.6

3.0

4.8

4.5

kpa

1.45

476

2744

(3023323) Follitropin [Units/volume] in Serum or Plasma

125

396

3.22

31.53

1.7

1.3

32.6

28.0

iu/l

0.61

336

(40768795) Lymph node Pathology biopsy report

7.09

31.35

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1098

7832

1.55

31.16

4.9

3.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

9.55

30.61

10.6

1.5

55.1

41.5

u/l

0.67

(40761536) Microorganisms panel - Urine sediment

430

2412

1.88

30.07

5.6

4.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.88

29.80

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

276

3.61

29.73

1.5

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

6.46

29.41

6.9

1.1

26.2

69.9

u/ml

0.94

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

236

1079

2.26

28.83

2.3

1.5

1.6

2.6

ratio

0.77

(3010421) pH of Blood

199

851

2.41

28.36

5.1

4.4

7.4

2.25

185

704

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

146

538

2.78

28.23

4.9

3.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

433

2482

1.83

28.20

2.1

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

239

1115

2.21

27.80

2.4

1.5

56.2

51.0

mg/l

0.61

196

899

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

238

1111

2.21

27.64

2.4

1.5

72.3

42.1

mg/l

0.76

194

891

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

179

741

2.48

27.38

2.2

2.4

3.9

3.5

g/l

1.62

172

702

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

165

659

2.57

27.22

3.7

1.5

50.9

24.1

u/ml

1.85

154

623

(40768446) Kidney Pathology biopsy report

121

4.93

27.16

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

300

1542

2.02

27.08

5.5

4.8

1.7

1.6

0.42

282

1449

(3007930) Methemoglobin/Hemoglobin.total in Blood

295

1511

2.03

26.88

5.6

4.9

0.9

2.78

278

1421

(3028626) Oxygen [Partial pressure] in Capillary blood

188

809

2.39

26.42

3.4

8.3

8.0

kpa

1.17

177

747

(3021901) Oxygen saturation in Capillary blood

160

644

2.55

25.98

3.4

2.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3409

31075

1.60

25.91

26.9

14.1

34.9

25.3

mg/l

40.00

3161

24482

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

208

944

2.27

25.86

1.3

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1519

11916

1.44

25.79

5.6

4.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

115

4.92

25.75

2.4

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

276

1402

2.04

25.72

4.4

3.0

4.3

4.4

pmol/l

1.28

247

1206

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

119

4.84

25.71

2.4

2.0

18.9

14.9

0.50

(40767503) Oxygen content in Capillary blood by calculation

170

711

2.45

25.45

3.2

2.5

16.3

16.4

0.07

101

379

(3009508) Creatinine [Moles/volume] in Urine

1482

11669

1.42

24.24

3.7

3.2

7.1

7.6

mmol/l

3.87

1227

9727

(3036782) Glucose [Moles/volume] in Pleural fluid

262

3.37

23.88

1.4

1.3

6.2

6.8

mmol/l

0.72

235

(40768793) Breast Pathology biopsy report

139

4.37

23.85

1.3

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

362

2069

1.82

23.67

1.9

1.6

—

(3011412) CD3 cells [#/volume] in Blood

164

4.01

23.11

2.3

1.8

1.0

1.1

e9/l

0.28

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

122

457

2.72

22.90

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

162

4.00

22.66

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

201

3.63

22.20

1.2

1.3

16.2

10.7

u/l

0.83

177

(3052851) Hemolysis interference index of Serum or Plasma

195

922

2.17

21.94

3.8

3.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.53

21.72

2.0

2.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.98

21.66

1.9

2.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

901

6577

1.48

21.63

1.7

1.6

1.3

mg/l

1.62

735

5092

(3012516) Albumin [Mass/volume] in Urine

1438

11430

1.40

21.62

3.8

3.3

519.9

270.5

mg/l

1.31

990

7408

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

147

622

2.41

21.48

1.3

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

150

643

2.38

21.30

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

187

882

2.17

21.17

1.9

1.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

177

819

2.21

21.02

2.3

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1503

12083

1.39

20.93

4.6

4.0

23.6

8.6

mg/mmol

11.88

1018

7764

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

418

2582

1.69

20.76

4.0

2.4

48.3

62.4

ml/min/173m2

19.68

258

995

(3022313) Gas panel - Capillary blood

296

1662

1.84

20.45

4.8

4.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

158

710

2.27

20.14

1.3

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1109

8515

1.42

20.05

5.7

4.1

0.0

estimate

0.40

440

2548

(3011985) Renin [Units/volume] in Plasma

110

422

2.65

19.75

1.7

1.4

50.9

70.5

mu/l

0.54

372

(3015235) Bicarbonate [Moles/volume] in Capillary blood

190

929

2.10

19.62

3.7

3.1

23.8

24.9

mmol/l

2.83

170

818

(3007853) Bacteria identified in Skin by Aerobe culture

547

3673

1.57

19.30

2.0

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

153

691

2.26

19.28

2.2

2.3

217.7

196.2

2.01

148

660

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

332

1966

1.75

19.18

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1653

13632

1.36

19.11

4.7

4.0

77.1

82.2

ng/l

0.05

1350

10240

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

212

1090

2.00

19.09

2.3

2.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1543

12615

1.36

18.76

2.6

2.2

79.8

78.7

nmol/l

0.74

1393

10963

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

162

758

2.18

18.74

2.1

89.7

89.0

0.13

156

723

(3024928) Oxygen saturation in Venous blood

160

749

2.18

18.49

3.7

3.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

328

2.78

17.88

1.5

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

323

2.79

17.82

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

103

403

2.60

17.81

2.0

1.5

112.1

128.3

u/ml

0.42

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

111

456

2.47

17.35

1.9

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

241

3.07

17.32

2.7

1.9

20.1

648.4

u/ml

0.60

236

(40760892) CBC W Ordered Manual Differential panel - Blood

818

6084

1.43

17.29

5.1

4.2

—

(3017181) Myelocytes/100 leukocytes in Blood

384

2430

1.64

17.28

4.0

3.7

0.7

0.8

0.17

144

531

(3037756) Immunofixation for Serum or Plasma

146

678

2.20

17.23

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

8.79

16.77

1.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1392

11347

1.34

16.74

3.2

2473.2

1628.9

ng/l

4.70

1250

9784

(3036489) Thrombin time

192

1006

1.95

16.40

2.0

1.9

22.7

21.4

1.34

176

891

(3010375) cycloSPORINE [Mass/volume] in Blood

112

4.05

16.37

25.6

24.2

84.7

118.2

ug/l

4.23

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

304

2.77

16.36

1.3

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

101

4.19

16.00

29.7

35.7

6.3

7.4

ug/l

2.83

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

907

6959

1.39

15.87

4.7

4.1

1391.1

517.9

ng/l

0.45

794

5886

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

399

2.49

15.65

1.3

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

127

580

2.23

15.64

1.4

1.7

2.4

4.6

iu/l

4.32

176

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

248

1433

1.78

15.58

5.3

4.2

24.2

24.8

mmol/l

2.29

233

1303

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2157

18848

1.31

15.38

3.6

3.0

63.1

50.7

u/l

6.23

1986

17124

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

489

2.33

15.34

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

157

792

2.02

14.96

2.9

2.2

128.0

130.8

g/l

0.66

126

587

(3002179) Metamyelocytes/100 leukocytes in Blood

348

2230

1.61

14.85

3.9

3.6

0.6

0.5

0.25

104

393

(3044889) 12 lead EKG panel

2545

22804

1.31

14.77

4.9

4.2

—

(3035880) pH of Pleural fluid

159

3.36

14.75

1.4

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

393

2.45

14.69

3.6

3.1

1.2

1.4

0.41

288

(3011397) Hemoglobin [Presence] in Urine by Test strip

975

7654

1.36

14.63

4.7

3.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

400

2.43

14.61

1.3

241.8

269.7

pmol/l

0.57

301

(3019225) pH of Specimen

474

3274

1.51

14.49

8.0

3.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

359

2339

1.59

14.28

4.1

3.8

0.1

0.24

135

495

(40768441) Liver Pathology biopsy report

116

3.74

14.04

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

239

1409

1.74

14.01

1.8

1.4

3.9

3.8

g/l

0.17

168

998

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

239

1411

1.74

13.94

1.8

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

239

1411

1.74

13.94

1.8

1.4

7.8

7.4

g/l

1.32

172

1036

(3013512) EKG study

1233

10117

1.31

13.47

4.9

4.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

385

2.39

13.43

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

224

1316

1.74

13.30

1.9

1.4

10.6

10.3

g/l

0.32

183

1090

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

205

1176

1.78

13.22

2.1

1.5

1.3

0.5

g/l

1.39

180

996

(3022145) Colonoscopy Study observation

441

3059

1.50

13.16

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

414

2.33

13.12

6.6

6.7

12.1

12.2

mg/l

0.10

373

(3025159) Blasts/100 leukocytes in Blood

340

2231

1.57

13.11

4.2

3.8

0.2

0.3

0.20

118

435

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

275

1718

1.64

12.99

3.9

2.6

1.2

0.04

275

1706

(3051651) Icteric interference index of Serum or Plasma

158

3.19

12.85

4.8

4.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

223

1324

1.72

12.76

1.9

1.4

3.4

3.0

g/l

4.25

171

1020

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

110

516

2.16

12.75

3.6

3.3

59.7

58.7

0.34

110

516

(3002385) Erythrocyte distribution width [Ratio]

2736

24969

1.29

12.66

35.7

16.8

14.3

13.7

48.54

2693

24262

(3027273) Bicarbonate [Moles/volume] in Venous blood

292

1864

1.61

12.65

5.1

3.1

24.5

25.2

mmol/l

3.50

285

1792

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.48

12.58

4.5

4.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

441

2.25

12.58

1.3

—

(3016750) Collection duration of Urine

225

2.78

12.52

1.9

2.0

503.6

491.0

min

0.48

167

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

237

2.73

12.44

1.2

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

301

2.52

12.42

4.0

3.0

—

(3045142) Bone marrow Pathology biopsy report

232

2.74

12.38

1.3

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

400

2.30

12.35

1.2

1.3

—

(40761535) Cells panel - Urine sediment

420

2944

1.48

11.87

4.5

3.3

—

(40768797) Stomach Pathology biopsy report

569

4219

1.41

11.86

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

433

2.22

11.84

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1034

8415

1.31

11.68

1.7

1.5

18.7

20.2

nmol/l

2.53

917

7102

(3005719) IgG [Mass/volume] in Serum or Plasma

301

1974

1.57

11.63

2.6

2.2

10.5

10.8

g/l

0.61

274

1802

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

230

1416

1.66

11.52

1.3

1.2

156.1

122.6

iu/ml

0.50

515

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

212

1281

1.69

11.40

2.0

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

130

682

1.94

11.16

1.7

2.6

27.8

35.6

umol/l

3.39

579

(3021387) Prolactin [Units/volume] in Serum or Plasma

104

504

2.09

11.13

1.6

1.8

324.9

294.5

mu/l

0.56

466

(3008757) Leukocyte morphology finding [Identifier] in Blood

282

2.47

11.04

3.7

3.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

210

1279

1.68

10.97

2.4

466.3

679.3

ug/l

0.55

203

1211

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

178

1040

1.74

10.82

1.8

1.4

0.0

g/l

0.53

167

944

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

166

952

1.78

10.77

1.8

1.5

0.0

g/l

0.00

158

870

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

139

3.12

10.70

2.2

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

168

969

1.77

10.69

1.8

1.4

0.0

g/l

0.00

158

874

(3000570) Elastase.pancreatic [Mass/mass] in Stool

154

866

1.81

10.67

1.4

246.4

284.0

ug/g

1.49

526

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2524

23033

1.25

10.52

6.3

3.7

15.2

15.0

pmol/l

3.80

2312

20534

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

101

3.49

10.42

2.7

2.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

189

1137

1.69

10.36

4.7

4.4

4.0

3.9

mmol/l

2.94

179

1064

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

221

1386

1.63

10.32

2.1

1.7

—

(3025315) Body weight

6.32

10.26

6.6

4.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

189

2.72

9.97

1.5

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

184

1111

1.69

9.96

1.9

1.4

36.1

37.6

g/l

2.49

162

928

(3017446) Testosterone [Moles/volume] in Serum or Plasma

326

2250

1.49

9.94

2.2

11.7

14.8

nmol/l

7.80

273

1968

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

119

633

1.91

9.85

1.4

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

434

2.10

9.81

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1293

11015

1.25

9.78

2.2

192.6

237.6

u/l

1.10

1213

10272

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

402

2.14

9.74

1.3

284.5

279.0

u/ml

0.06

244

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.74

9.58

1.3

1.2

191.1

75.5

ug/l

—

(4281824)

144

2.94

9.48

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

136

2.96

9.18

2.3

1.6

736.3

713.2

e6/l

0.04

(3020891) Body temperature

229

1491

1.57

9.17

6.0

4.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

270

2.35

9.16

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

270

2.35

9.16

1.2

1.1

68.1

60.1

u/l

0.20

175

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

123

678

1.84

9.14

1.6

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3470

33101

1.33

9.11

34.6

17.3

139.0

139.8

mmol/l

51.24

3417

32139

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

160

2.77

8.95

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

218

2.50

8.94

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

18.62

8.92

1.2

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

161

2.75

8.85

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.79

8.77

1.2

398.4

232.0

pmol/l

0.76

(3004775) Volume in Urine collected for unspecified duration

327

2.19

8.73

2.0

2.3

680.0

624.0

0.61

214

(3028026) IgM [Mass/volume] in Serum or Plasma

236

1566

1.54

8.69

2.2

1.4

1.7

1.1

g/l

1.31

216

1409

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1761

15669

1.22

8.52

2.6

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3471

33181

1.31

8.45

35.0

17.4

4.1

4.0

mmol/l

54.68

3415

32165

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.17

8.40

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

107

581

1.86

8.37

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

4.46

8.36

1.6

1.1

2.2

3.0

ug/l

0.37

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

155

2.73

8.33

2.1

2.2

—

(40761511) CBC panel - Blood by Automated count

3370

32123

1.28

8.15

27.2

13.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3100

29262

1.25

8.13

29.8

13.1

62.4

75.2

ml/min/173m2

164.12

2835

23605

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

247

2.33

8.12

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

109

3.04

7.99

2.8

2.2

27.9

44.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

165

2.62

7.93

1.6

1.4

4.5

5.9

u/l

0.25

(3042631) Mycobacterium sp identified in Specimen

429

1.98

7.91

2.0

3.1

—

(3003181) Sodium [Moles/volume] in Urine

107

594

1.82

7.83

1.4

1.3

53.2

63.4

mmol/l

2.62

472

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

2.80

7.73

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.20

7.65

2.5

2.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

159

996

1.62

7.54

2.7

2.2

209.4

123.4

ug/min

1.13

590

(3051611) Lipemic interference index of Serum or Plasma

314

2.12

7.54

4.3

3.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

124

729

1.72

7.48

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

124

729

1.72

7.48

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

119

2.87

7.47

2.5

1.5

487.2

442.8

e6/l

0.25

106

(3036603) Volume of Urine

171

2.53

7.40

1.6

1.4

1739.6

1906.0

—

(3000060) B lymphocytes [#/volume] in Blood

4.86

7.40

3.4

1.7

205.0

187.4

e6/l

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

220

2.33

7.38

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

220

2.33

7.38

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

220

2.33

7.38

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

2.44

7.32

1.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

110

2.92

7.26

1.5

1.4

59.3

65.5

0.41

(3018834) Bilirubin.total [Presence] in Urine by Test strip

15.76

7.22

12.6

1.1

0.0

—

estimate

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

180

2.46

7.15

2.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

112

2.87

7.04

2.6

1.5

0.3

0.2

e9/l

0.48

104

(3042111) Morphology [Interpretation] in Bone marrow Narrative

434

1.91

7.00

1.5

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

160

2.51

6.83

1.4

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

191

2.37

6.78

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.26

6.74

1.2

0.8

3.5

mmol/l

0.67

(3025941) Bacteria identified in Stool by Culture

219

1514

1.47

6.69

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

110

650

1.71

6.57

1.4

1.3

—

(3047189) Immunofixation for 24 hour Urine

134

2.63

6.54

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

104

607

1.73

6.49

1.7

1.2

58.3

29.2

u/l

0.67

523

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

135

2.61

6.45

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

135

2.61

6.45

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

173

2.38

6.28

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

187

2.31

6.16

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1635

14760

1.18

6.05

2.1

94.1

93.1

pmol/l

0.34

922

7707

(3024891) Influenza virus A+B Ag [Presence] in Specimen

114

700

1.65

5.93

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

270

2.05

5.87

3.3

2.8

58.0

59.8

0.21

169

(3042733) HLA Ab [Presence] in Serum

2.87

5.77

6.5

4.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

108

2.70

5.75

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

108

2.70

5.75

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

108

2.70

5.75

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

108

2.70

5.75

1.2

—

(3045414) Leukocytes [Presence] in Urine

207

1461

1.44

5.72

2.2

1.9

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

156

2.38

5.71

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

195

2.22

5.62

1.0

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

110

2.65

5.56

2.7

2.9

16.6

20.4

mu/l

0.60

101

(44790049)

306

1.94

5.43

1.5

1.4

—

(44790048)

306

1.94

5.43

1.5

1.4

—

(44790047)

306

1.94

5.43

1.5

1.4

—

(44806118)

306

1.94

5.43

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

118

751

1.59

5.35

1.4

1.9

12.6

11.8

mg/l

0.38

108

686

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

2.40

5.21

1.2

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

442

1.76

5.17

1.3

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

628

5258

1.23

5.16

27.4

29.8

1.5

inr

0.04

700

(3017732) Neutrophils [#/volume] in Blood

270

2031

1.35

5.15

3.9

3.2

4.4

4.2

e9/l

0.67

209

1445

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

168

1169

1.46

5.04

1.5

117.8

280.0

titre

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.77

5.03

1.6

1.4

0.9

2.5

1.49

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.82

4.97

1.7

1.4

24.9

23.2

0.09

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

404

1.77

4.93

1.1

1.0

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

143

2.32

4.84

1.2

41.9

21.6

u/l

1.12

122

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

175

2.18

4.83

1.9

1.8

2.0

2.8

u/field

0.24

120

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.07

4.78

1.2

1.1

—

(3024471) HLA-A [Type]

2.75

4.77

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.79

4.71

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

106

1611

0.65

4.66

1.3

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.15

4.62

1.1

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.76

4.60

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.76

4.60

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

147

2.26

4.56

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

147

2.26

4.56

1.1

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1177

0.60

4.55

1.8

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.98

4.55

2.0

1.5

184.7

138.9

ng/l

0.57

(3024932) HLA-DR beta [Type]

2.69

4.41

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

352

1.77

4.38

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

303

1.83

4.30

1.3

1.4

276.7

278.2

mosm/kgh2o

0.13

230

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

362

1.75

4.28

1.5

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.79

4.28

1.7

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

355

1.76

4.27

1.5

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

2852

27249

1.16

4.25

31.0

15.5

37.7

39.5

14.61

1837

17471

(3000494) Fungus identified in Specimen by Culture

431

3541

1.24

4.22

1.6

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.84

4.22

1.0

1.2

0.7

umol/24h

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3438

33347

1.20

4.21

36.7

16.4

111.3

83.2

umol/l

90.59

3438

33335

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

127

2.29

4.19

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

127

2.29

4.19

1.3

1.4

—

(3014891) Appearance of Pleural fluid

3.42

4.18

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

380

1.72

4.17

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2981

28591

1.16

4.15

7.0

4.5

2.1

mu/l

0.72

2744

25646

(3000093) Morphology [Interpretation] in Blood Narrative

314

1.79

4.14

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

125

857

1.47

4.11

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

141

2.21

4.11

1.4

0.2

0.3

nmol/l

0.64

115

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

170

1234

1.39

4.10

1.5

1.8

36.9

38.0

u/l

0.29

144

1034

(3032352) Blasts [#/volume] in Cerebral spinal fluid

8.01

4.06

1.3

—

(3004451) EKG impression Narrative

182

2.04

4.03

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

347

1.74

4.01

1.5

1.3

—

(1761868) Lipid panel - Serum or Plasma

854

9650

0.85

4.01

3.3

3.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

125

863

1.46

3.98

1.2

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

348

1.73

3.98

1.5

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

2.82

3.95

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

825

7252

1.17

3.94

5.9

4.1

1.0

kg/l

0.15

144

1107

(3005988) Vibrio sp identified in Specimen by Organism specific culture

350

1.72

3.90

1.5

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

125

869

1.45

3.86

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

146

2.13

3.80

1.1

131.0

88.1

u/l

0.51

110

(40765096) Chromosome analysis panel by Banding

3.19

3.77

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

265

1.82

3.77

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

147

2.12

3.74

1.1

80.5

26.1

u/l

0.66

105

(3022493) Free Hemoglobin [Mass/volume] in Plasma

154

2.09

3.72

1.3

6.4

63.0

70.9

mg/l

0.27

102

(3043410) Blood group antigens tested for on Red Blood Cells

2.57

3.71

2.0

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

136

974

1.41

3.59

6.0

4.0

—

(3000012) Reticulocyte production index

184

1.97

3.57

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.65

3.56

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3103

32032

0.87

3.53

5.4

5.5

2.5

2.6

mmol/l

4.80

2787

29203

(3025549) Creatine [Moles/time] in 24 hour Urine

3.85

3.52

2.3

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.16

3.50

4.9

4.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

113

2.22

3.41

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

404

1.62

3.38

3.3

25.5

6.9

7.6

mmol/l

1.15

333

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

7.01

3.36

8.6

5.2

501.3

359.3

umol/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

235

1849

1.29

3.36

2.4

2.5

—

(3020393) Adenovirus Ag [Presence] in Stool

3.71

3.35

1.0

1.9

—

(3045424) Erythrocytes [Presence] in Urine

533

1.53

3.31

1.6

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.62

3.30

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

190

1.90

3.28

2.8

1.6

439.2

2692.2

u/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3027

31259

0.88

3.28

4.9

4.8

4.4

4.5

mmol/l

4.76

2744

28622

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2999

30988

0.88

3.28

4.8

1.3

1.4

mmol/l

30.08

2702

28178

(3022621) pH of Urine by Test strip

273

2199

1.26

3.23

3.6

3.1

—

(3011648) Oxygen content in Venous blood

257

1.76

3.21

3.3

2.0

9.5

10.9

1.48

257

(3007164) IgA [Mass/volume] in Serum or Plasma

577

5008

1.18

3.21

1.5

1.3

2.6

2.7

g/l

0.43

353

2828

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

5.34

3.19

1.0

—

(3000330) Specific gravity of Urine by Test strip

234

1855

1.28

3.17

5.1

3.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

138

1854

0.74

3.16

2.0

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

193

1.87

3.15

1.1

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3416

33285

1.16

3.13

17.3

9.4

27.5

26.0

u/l

0.49

3309

31712

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

289

1.70

3.13

2.6

2.1

3.9

1.7

u/field

1.06

105

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

408

3444

1.21

3.11

3.0

3.1

319.0

226.8

ng/l

1.81

381

3171

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.08

2.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.24

3.05

1.3

1.2

22.6

15.1

u/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

105

742

1.43

3.04

1.2

92.9

112.1

titre

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.44

3.04

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

432

1.56

3.03

2.4

2.2

14.8

24.8

mg/l

2.19

103

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

10.01

2.98

1.2

1.8

76.7

13.2

ng/l

—

(3022475) Manganese [Moles/volume] in Blood

10.01

2.98

1.6

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

144

1.95

2.79

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.45

2.79

1.9

4.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.45

2.79

4.5

3.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

209

1.78

2.78

2.1

2.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

137

1033

1.34

2.72

1.4

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

280

1.65

2.67

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.13

2.64

1.1

1.2

2.0

1.9

umol/24h

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1658

15588

1.11

2.61

5.2

3.9

3.3

2.4

ug/l

1.22

1478

13985

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

862

0.66

2.60

1.5

1.6

6.0

4.2

mg/l

0.52

599

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.61

2.57

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.73

2.54

3.7

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

575

1.43

2.54

1.6

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

814

7365

1.13

2.53

1.8

1224.7

1149.3

nmol/l

1.06

623

5494

(3016038) Potassium [Moles/volume] in Urine

232

1.69

2.48

1.1

34.6

34.7

mmol/l

0.01

195

(3023410) Appearance of Cerebral spinal fluid

255

1.65

2.48

1.5

1.3

—

(40768443) Skin Pathology biopsy report

160

1252

1.29

2.47

1.3

1.2

—

(21494434) Karyotype in Bone marrow

256

1.65

2.45

1.1

1.2

—

(4034850)

1178

0.72

2.44

17.0

10.4

—

(3017704) Immunofixation for Urine

203

1.73

2.44

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

472

1.47

2.44

3.4

2.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

241

1.67

2.43

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2913

29990

0.90

2.42

4.4

4.3

1.5

1.3

mmol/l

26.30

2594

27028

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.75

2.37

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

510

1.44

2.33

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

420

3651

1.17

2.33

2.6

2.4

5.2

7.6

ug/l

2.85

368

3167

(3037522) Nuclear Ab [Titer] in Serum

440

3844

1.16

2.29

1.3

511.3

525.0

titre

0.04

828

(3041354) Potassium [Moles/volume] in Venous blood

482

1.44

2.22

3.4

2.2

4.3

4.1

mmol/l

3.71

477

(3035285) Chloride [Moles/volume] in Venous blood

482

1.44

2.22

3.4

2.2

105.0

105.9

mmol/l

0.72

477

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.56

2.21

6.2

5.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.78

2.20

1.0

—

(3044927) Protein electrophoresis panel - Urine

430

1.45

2.09

1.3

1.2

—

(3023419) Bacteria identified in Sputum by Culture

464

1.43

2.07

2.0

2.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.91

2.07

1.1

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.91

2.07

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

191

1.68

2.06

1.2

1.3

1.5

1.2

nmol/l

0.22

144

(3016018) Differential panel - Cerebral spinal fluid

269

1.57

2.05

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

101

766

1.33

2.01

2.3

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

163

1.72

1.98

1.6

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

163

1.72

1.98

1.6

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

359

3137

1.16

1.90

2.3

2.2

240.6

159.3

ug/g

0.63

275

2458

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

340

1.48

1.89

3.0

3.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.09

1.86

1.5

1.4

2.2

2.0

umol/l

0.53

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.94

1.84

1.0

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

112

877

1.28

1.80

4.6

3.0

1.5

1.7

mmol/l

0.98

112

852

(3038515) Glucose [Moles/volume] in Venous blood

107

833

1.29

1.80

4.7

3.1

7.3

7.8

mmol/l

1.03

107

808

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.05

1.80

1.3

2.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.00

1.79

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.34

1.74

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.98

1.74

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.23

1.73

2.0

1.4

13.4

45.2

u/l

0.58

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.67

1.72

1.3

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

144

1172

1.24

1.69

1.2

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

2.80

1.65

3.1

3.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

2.80

1.65

6.3

7.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

590

1.33

1.64

1.1

1.2

4.3

6.5

u/ml

—

(3048879) Bone marrow aspiration report

1.98

1.64

1.5

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.33

1.60

2.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

493

0.67

1.54

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

267

3055

0.87

1.52

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

124

1.70

1.47

2.1

2.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.23

1.46

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.88

1.44

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.73

1.43

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

374

3350

1.13

1.43

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

107

862

1.25

1.43

1.7

1.6

0.3

3.7

iu/ml

0.56

200

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

118

1.70

1.41

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

157

1.60

1.40

1.1

1.2

127.0

142.8

nmol/l

1.53

157

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.42

1.39

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.61

1.36

1.0

—

(4062490)

273

1.43

1.35

1.1

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.76

1.34

1.7

1.6

—

(4015189)

105

1.72

1.33

2.5

2.7

—

(3019977) pH of Arterial blood

209

1.49

1.30

2.0

2.2

7.4

0.86

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.78

1.28

3.0

1.3

—

(3008898) HLA-B27 [Presence]

734

0.76

1.25

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.40

1.24

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

179

1.51

1.23

2.3

2.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

139

1.59

1.23

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.16

1.21

1.9

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

820

7707

1.08

1.20

1.8

1.7

18871149.6

28626494.0

pmol/l

0.20

673

6274

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.11

1.18

1.8

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

1.15

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

1.15

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

1.15

1.4

1.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

274

1.39

1.15

1.0

1.4

2.6

3.0

g/l

0.61

197

(3027135) IgG subclass 1 [Mass/volume] in Serum

274

1.39

1.15

1.0

1.4

6.7

6.8

g/l

0.08

199

(3024139) IgG subclass 3 [Mass/volume] in Serum

274

1.39

1.15

1.0

1.4

0.4

g/l

0.58

198

(3024980) IgG subclass 4 [Mass/volume] in Serum

431

1.30

1.12

1.3

1.7

0.9

g/l

0.00

334

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3068

31190

0.93

1.12

5.7

5.1

6.2

6.1

mmol/l

2.12

2760

28025

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

111

1.62

1.12

1.2

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

122

1029

1.19

1.10

1.7

1.5

—

(3021788) Differential panel - Synovial fluid

639

1.24

1.08

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

338

1.34

1.08

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.87

1.07

1.8

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

924

8764

1.07

1.06

3.2

2.8

0.9

0.7

ug/l

4.45

698

6067

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.06

1.02

1.0

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.69

1.01

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

564

1.25

1.01

1.3

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

299

1.34

1.00

1.1

—

2.3

—

(3025577) Chromium [Mass/volume] in Blood

262

0.65

1.00

2.4

2.0

3.6

2.0

ug/l

0.38

217

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.18

0.98

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.97

0.0

1.1

—

26.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.67

0.97

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.95

0.97

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

241

1.37

0.96

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

364

1.29

0.94

3.5

3.1

85.7

36.3

mg/l

0.94

276

(3026389) Candida sp identified in Specimen by Organism specific culture

364

1.29

0.94

1.8

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

697

1.21

0.93

1.6

1.5

1.0

0.8

nmol/l

1.19

570

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.22

0.93

1.8

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

256

0.66

0.91

1.4

87.3

202.4

pmol/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

244

1.36

0.90

1.2

217.1

155.3

titre

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

332

1.30

0.89

1.1

—

(3003338) MCHC [Mass/volume]

2522

25715

0.95

0.89

38.2

18.5

329.7

332.7

g/l

42.61

2500

25463

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.69

0.88

1.4

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

154

0.58

0.88

1.3

1.4

—

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

831

1.18

0.88

1.9

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

128

1110

1.16

0.87

1.5

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

712

1.20

0.87

1.1

1.2

3.1

5.6

u/ml

—

118

(3007461) Platelets [#/volume] in Blood

3480

34434

1.07

0.87

42.5

20.6

245.3

239.8

e9/l

4.70

3417

33278

(3003740) Influenza virus B Ag [Presence] in Specimen

272

1.33

0.87

1.1

—

(3016879) Cocaine [Presence] in Urine

387

1.27

0.86

1.5

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.82

0.85

2.5

2.7

0.3

0.4

u/field

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

317

1.30

0.85

1.1

1.3

—

(3024731) MCV [Entitic volume]

3480

34443

1.07

0.84

42.2

20.5

91.2

91.5

3.00

3442

33732

(3035941) MCH [Entitic mass]

3480

34444

1.07

0.84

42.2

20.5

30.1

30.5

26.38

3442

33736

(3026361) Erythrocytes [#/volume] in Blood

3480

34446

1.07

0.83

42.4

20.6

4.4

4.5

e12/l

48.17

3404

33150

(3000963) Hemoglobin [Mass/volume] in Blood

3480

34451

1.07

0.81

42.7

20.7

129.4

136.6

g/l

117.02

3444

33746

(3005322) IgE [Units/volume] in Serum or Plasma

184

1646

1.12

0.81

1.3

249.8

251.1

u/ml

0.01

164

1520

(3001019) Free T4 and TSH panel - Serum or Plasma

796

0.83

0.81

1.7

—

(3010813) Leukocytes [#/volume] in Blood

3480

34453

1.07

0.81

42.5

20.6

7.2

6.8

e9/l

20.61

3402

33156

(1001926) Buprenorphine [Presence] in Urine by Screen method

320

1.28

0.80

1.5

1.9

—

(3026470) Cobalt [Mass/volume] in Blood

270

0.70

0.78

2.2

1.9

12.3

3.2

ug/l

0.40

237

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

431

4609

0.93

0.78

12.7

7.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.78

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.78

0.0

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.53

0.78

1.3

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

115

1.48

0.76

1.1

—

(3044941) Cell count panel - Synovial fluid

576

1.20

0.76

1.4

1.3

—

(4133840)

1.60

0.74

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

210

1.34

0.73

1.8

—

(3006270) Folate [Moles/volume] in Blood

316

1.27

0.73

1.2

321.8

334.0

nmol/l

0.14

250

(3000492) Spirometry study

288

2657

1.09

0.72

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.80

0.72

1.1

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

211

1.33

0.71

1.7

—

(3027008) Opiates [Presence] in Urine

416

1.23

0.71

1.5

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

1.62

0.71

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

0.71

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

273

1.28

0.71

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2981

30194

0.95

0.71

7.2

6.6

41.3

40.9

mmol/mol

1.40

2749

27641

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

1.47

0.70

2.0

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

109

1.47

0.70

2.0

2.5

—

(3028300) Cannabinoids [Presence] in Urine

417

1.23

0.70

1.5

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

139

1237

1.13

0.70

1.6

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.71

0.70

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

703

1.17

0.69

1.1

1.2

2.1

2.9

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.64

0.68

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

485

0.80

0.67

3.7

4.3

310.6

352.6

umol/l

1.07

410

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

136

1.40

0.66

1.1

1.2

1.1

ratio

—

(3028707) Methadone [Presence] in Urine by Screen method

197

1.32

0.65

1.5

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

412

1.22

0.65

1.5

1.9

—

(3032057) Clostridioides difficile [Presence] in Stool

1.54

0.65

1.7

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

215

1.30

0.65

2.0

1.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

293

0.75

0.64

1.0

1.1

0.8

1.2

u/ml

—

127

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

377

1.22

0.64

1.2

5.6

5.5

u/ml

0.01

173

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

130

0.61

0.63

1.5

1.8

25.7

78.4

ug/l

—

121

(4306422)

369

1.22

0.62

1.1

1.2

—

(4268621)

252

1.27

0.62

2.2

2.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

435

0.80

0.61

1.1

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

130

1.39

0.61

1.4

2.3

110.1

95.0

0.75

122

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

490

1.19

0.60

1.0

1.1

1.5

418.5

iu/ml

0.67

(3014271) Vancomycin [Susceptibility]

218

1.29

0.60

2.6

3.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.59

0.0

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

131

1.38

0.59

2.6

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.44

0.59

1.1

—

(4094501)

935

0.87

0.57

1.1

—

(3027944) Amphetamines [Presence] in Urine

411

1.19

0.56

1.5

1.8

—

(4024509)

348

1.21

0.55

1.3

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.58

0.54

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.54

0.53

1.2

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.45

0.53

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

187

1.29

0.52

1.4

5.7

6.5

u/l

0.49

158

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.62

0.52

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.50

0.51

1.0

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.39

0.50

1.3

1.2

100.1

102.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

178

0.73

0.48

1.7

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.52

0.48

1.3

1.7

—

(3052592) Norovirus Ag [Presence] in Stool

1.45

0.48

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

1.46

0.46

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

221

0.77

0.46

1.1

3.1

2.4

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

637

1.13

0.45

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1286

12568

1.03

0.45

4.4

3.8

23.3

24.2

1.43

700

6193

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

647

1.13

0.45

1.2

4.0

3.9

mmol/l

0.19

600

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.40

0.44

1.9

1.4

12.5

9.1

ug/l

1.07

(3003888) Timothy IgE Ab [Units/volume] in Serum

296

0.81

0.43

1.0

1.1

6.6

3.7

u/ml

—

147

(3010726) Horse dander IgE Ab [Units/volume] in Serum

252

0.79

0.43

1.1

2.0

2.1

u/ml

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.41

0.43

1.3

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.43

0.42

1.3

1.2

—

64.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.43

0.42

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.56

0.42

1.0

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

406

1.16

0.42

1.0

1.2

139.3

193.8

miu/ml

0.43

149

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.43

0.41

2.0

3.2

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.41

0.0

1.7

—

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

6.9

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

897

8730

1.04

0.40

1.7

1.6

1.3

mmol/l

9.08

760

7219

(3020650) Glucose [Presence] in Urine

1.39

0.40

1.3

1.5

—

(3033799) Differential panel - Peritoneal fluid

1.39

0.40

1.6

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.47

0.40

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

132

1.29

0.40

1.2

1.1

1.0

1.1

u/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

609

5887

1.04

0.40

1.2

1.3

1.8

1.9

u/ml

0.06

141

1508

(3050129) First trimester maternal screen panel - Serum or Plasma

103

0.68

0.39

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

391

1.15

0.38

1.2

5.6

4.5

u/ml

0.11

122

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

151

1.26

0.38

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

181

0.77

0.38

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

628

1.12

0.37

1.3

1.2

52.4

25.7

e6/l

0.27

499

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

628

1.12

0.37

1.4

1.3

615.3

871.9

e6/l

0.23

525

(3011288) Drugs identified in Urine by Screen method

262

1.18

0.37

2.3

2.7

—

(3009871) Measles virus Ab [Titer] in Serum

1.29

0.36

1.6

1.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

146

0.75

0.36

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

0.64

0.35

2.6

2.2

—

3.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.43

0.35

1.0

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.63

0.35

4.4

7.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

341

0.85

0.34

1.0

1.1

2.6

1.6

u/ml

0.20

144

(3017315) Amylase [Enzymatic activity/volume] in Urine

163

1.23

0.34

1.1

1.2

361.1

350.7

u/l

0.01

148

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.33

0.33

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

912

1.09

0.33

1.6

1.5

12081.7

13438.2

e6/l

0.23

668

(3019420) Tryptase [Mass/volume] in Serum or Plasma

109

1.29

0.33

1.7

1.6

8.8

9.8

ug/l

0.14

(3051101) Glucose [Moles/volume] in Cord blood

0.69

0.33

7.0

6.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

257

1.17

0.32

1.0

1.2

—

98.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

138

1.23

0.30

1.2

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

111

1.26

0.30

1.3

1.5

87.1

147.3

umol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

862

1.08

0.29

3.1

0.8

nmol/l

0.12

662

(1002224) Polysomnography panel

960

0.93

0.28

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

721

0.91

0.28

1.7

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.29

0.28

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

519

1.10

0.26

1.1

1.2

57.4

42.8

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

636

1.09

0.25

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

1.22

0.25

1.2

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

340

0.88

0.24

1.3

1.4

15.8

27.5

1.82

229

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.25

0.24

1.1

775.1

1683.9

miu/ml

4.02

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

456

1.10

0.23

1.6

1.5

74.6

63.6

1.40

306

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

153

1457

1.05

0.23

1.4

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.32

0.23

1.4

1.0

—

(3024263) Appearance of Synovial fluid

211

0.85

0.23

1.3

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

200

0.85

0.22

1.0

1.1

9.8

3.5

u/ml

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

253

0.87

0.22

1.1

1.2

1.3

promille

0.03

192

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

400

0.90

0.22

1.4

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

347

0.89

0.22

1.4

1.2

7.3

7.8

mmol/l

0.39

244

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

243

2517

0.96

0.21

1.3

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

9.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.16

0.21

1.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.25

0.20

4.0

2.2

45.7

45.6

umol/l

—

(3022689) Creatine [Moles/volume] in Urine

113

0.80

0.20

1.8

1.4

—

(3006462) Nitrate [Presence] in Urine

155

1.16

0.19

5.4

3.3

—

(3004616) Nuclear Ab [Presence] in Serum

376

1.09

0.18

1.0

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

363

0.91

0.18

1.4

1.2

32323.7

235159.5

e6/l

3.06

253

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

185

1.14

0.18

3.0

4.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

352

0.91

0.18

1.4

1.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

481

4908

0.98

0.17

1.3

42.0

39.2

iu/ml

0.13

152

1473

(4198724)

1.15

0.17

1.1

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

226

0.88

0.17

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.22

0.17

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.75

0.17

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

751

0.94

0.16

4.2

3.6

29.7

28.8

mg/l

0.07

495

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

120

1251

0.96

0.16

1.0

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

139

1.15

0.16

18.3

15.3

1572.9

1372.5

nmol/l

0.53

134

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.10

0.15

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.76

0.15

1.0

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.75

0.15

1.2

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

371

1.08

0.15

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

121

1.16

0.15

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.81

0.14

1.9

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.81

0.14

1.9

1.4

—

(4010399)

234

2402

0.97

0.14

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

368

0.92

0.14

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.17

0.13

21.5

7.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

455

4622

0.98

0.12

1.2

17.5

14.7

u/ml

0.25

149

1695

(44806420)

127

0.87

0.12

2.3

2.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1006

0.96

0.11

1.7

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

198

0.91

0.10

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

198

0.91

0.10

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

198

0.91

0.10

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

205

2007

1.02

0.10

1.3

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

193

1.09

0.10

1.1

0.2

10.0

nmol/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

524

0.95

0.09

1.1

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.09

0.09

1.0

1.1

—

2.7

—

(44813793)

165

0.91

0.08

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

449

1.05

0.08

1.6

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

897

0.97

0.08

1.6

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

814

1.03

0.08

1.8

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

195

0.92

0.08

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

195

0.92

0.08

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

195

0.92

0.08

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

293

1.06

0.08

1.1

11.9

3.0

u/ml

—

103

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.86

0.07

1.0

2.1

11.7

8.8

mg/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.80

0.07

1.5

2.0

17.4

14.6

g/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.80

0.07

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

108

1.11

0.07

19.8

7.6

—

(3025130) Human papilloma virus identified in Specimen

153

0.91

0.07

1.9

1.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.82

0.07

1.9

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.82

0.07

1.9

1.4

—

(3034426) Prothrombin time (PT)

1.05

0.07

1.0

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

216

1.07

0.06

1.3

1.2

15.8

11.8

mmol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.87

0.06

1.7

1.5

—

(3028433) Virus identified in Specimen by Culture

0.84

0.06

1.3

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

103

0.87

0.06

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

152

0.92

0.06

1.5

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

195

1922

1.02

0.06

2.3

2.4

32.9

27.5

au/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

131

0.92

0.05

1.1

1.2

48.9

40.5

g/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

435

4315

1.01

0.05

4.7

5.0

30.6

32.9

4.41

311

2827

(4027681)

139

1.08

0.05

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

228

1.05

0.05

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

169

1.07

0.05

1.2

1.1

—

(4211845)

169

1.07

0.05

5.4

3.2

—

(3020491) Glucose [Moles/volume] in Blood

248

1.05

0.05

1.9

2.4

8.2

6.8

mmol/l

1.14

167

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

120

0.92

0.05

1.4

1.5

—

(3051593) INR in Capillary blood by Coagulation assay

210

1.05

0.03

11.0

11.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

201

1.05

0.03

1.8

1.3

0.5

1.3

u/ml

0.71

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

430

0.98

0.02

1.5

1.9

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

710

0.99

0.02

1.9

223.2

202.3

pmol/l

0.67

666

(3015171) Extractable nuclear Ab [Units/volume] in Serum

107

1080

0.99

0.01

1.3

1.2

0.5

0.7

u/ml

—

108

(3045683) HLA typing for celiac disease panel - Blood or Tissue

123

1.06

0.01

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

699

0.99

0.01

1.1

4.9

9.5

u/ml

—

(4146454)

437

0.98

0.01

2.9

2.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

305

3041

1.00

0.01

1.6

1.8

1.6

0.06

253

2586

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.05

0.00

1.2

1.6

193.1

164.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

228

1.01

0.00

1.0

1.1

—

(36660697) Celiac disease serology panel - Serum

215

2155

1.00

0.00

1.2

—

(3015183) Erythrocyte sedimentation rate

1.01

0.00

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.01

0.00

2.1

2.3

2.2

1.1

ug/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

134

0.97

0.00

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

157

1.02

0.00

1.3

1.2

—

(3045716) Anion gap in Serum or Plasma

197

1.02

0.00

2.7

1.9

8.3

9.4

mmol/l

0.84

152

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

3.9

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.01

0.00

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.95

0.00

1.9

1.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.94

0.00

1.0

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.6

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.96

0.00

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.87

0.00

1.5

2.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

250.9

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

45.5

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.8

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1215.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.94

0.00

1.0

1.1

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.92

0.00

1.9

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.98

0.00

1.5

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

8.6

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.3

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

176.8

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.96

0.00

1.9

1.4

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_KIDNEY_NOTRENALPELVIS_EXALLC – Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

GWS hits: 10

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers) (C3_KIDNEY_NOTRENALPELVIS_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints